“A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report”, JOPIR, vol. 4, no. 2, pp. 252–258, Apr. 2026, doi: 10.69613/ss2yp015.